JAMES MCCLOSKEY: Open Payments
NPI 1750634267 · ABINGDON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,701 in 153 payments from 19 companies in 2025. Trend: 2023 $584 · 2024 $1,381 · 2025 $2,701
Food & beverage: $2,611Education: $90
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 26 | $653 |
| GENZYME CORPORATION | 11 | $392 |
| Janssen Biotech, Inc. | 32 | $346 |
| Novartis Pharmaceuticals Corporation | 14 | $208 |
| Regeneron Healthcare Solutions, Inc. | 15 | $175 |
| Galderma Laboratories, L.P. | 12 | $158 |
| ABBVIE INC. | 11 | $151 |
| Organon LLC | 7 | $113 |
| PFIZER INC. | 5 | $95 |
| LEO Pharma Inc. | 3 | $77 |
Products named: Bimzelx, DUPIXENT, TREMFYA, COSENTYX, NEMLUVIO, CIBINQO, SKYRIZI, RINVOQ.
Industry payments across MD — which companies pay providers there.
